MBXMBX Biosciences, Inc.

$54.03+146% 1Y

$54.03

$20.6152 weeks$70.67

The business

How MBX's business earns

Share count, year on year: +42%
Share count, year on year · more shares than a year ago

Details›

Free cash flow, trailing twelve months: −$99M
Net income, trailing twelve months: −$145M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Biotechnology

The closest names by size in the same industry

Palvella Therapeutics, Inc.

Arcus Biosciences, Inc.

Celldex Therapeutics, Inc.

Beam Therapeutics Inc.

ADMA Biologics, Inc.

ACADIA Pharmaceuticals Inc.

MBX Biosciences (MBX) Margins and Return on Capital · Ryufin